SAR438544 - Clinical & Exploratory Pharmacology

Trial Profile

SAR438544 - Clinical & Exploratory Pharmacology

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 16 Sep 2016

At a glance

  • Drugs SAR 438544 (Primary) ; Insulin
  • Indications Type 1 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors Sanofi
  • Most Recent Events

    • 29 Jul 2016 Status changed from not yet recruiting to withdrawn prior to enrolment since the company has decided not to pursue the development of SAR438544 in diabetes, according to a Sanofi media release.
    • 20 Apr 2016 Planned End Date changed from 1 Aug 2016 to 1 Nov 2016.
    • 20 Apr 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Nov 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top